
GC31057
Naluzotan
Also listed as Naluzotan (PRX 00023)
Naluzotan (PRX 00023) is a novel, potent, and selective amidosulfonamide 5-HT1A agonist with IC50 and Ki of appr 20 nM and 5·1 nM, used for the treatment of anxiety and depression; Also a weak hERG K+ channel blocker, with IC50 of 3800 nM
ChemicalCAS740873-06-7MW450.64FormulaC23H38N4O3S
- CAS number
- 740873-06-7
- Molecular weight
- 450.64
- Formula
- C23H38N4O3S
- Solubility
- Soluble in DMSO
- InChIKey
- SPWZXWDPAWDKQE-UHFFFAOYSA-N
- Catalogue number
- GC31057
- Brand
- GLPBIO
Computed properties PubChem CID 11430856 · XLogP 3.2 · TPSA 90.1 Ų · H-bond donors 2
- XLogP
- 3.2
- TPSA
- 90.1 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 10
- Heavy atoms
- 31
SMILES CC(=O)NC1=CC(=CC=C1)N2CCN(CC2)CCCCNS(=O)(=O)CC3CCCCC3
Computed descriptors from PubChem (CID 11430856), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il